Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 16
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohort

  • Segura, A. G
  • Mané, A.
  • Prohens, Ll.
  • Rodríguez, N.
  • Mezquida, G.
  • Cuesta, M. J
  • Vieta, E.
  • Amoretti, S.
  • Lobo, A.
  • González-Pinto, A.
  • Díaz-Caneja, C. M.
  • Roldán Bejarano, A.
  • Jiménez, E.
  • Baeza, I.
  • Legido, T.
  • Saiz-Ruiz, J.
  • Bernardo, M.
  • Mas, S.
  • PEPs Group
Cannabis use is highly prevalent in first-episode psychosis (FEP) and plays a critical role in its onset and prognosis, but the genetic underpinnings promoting both conditions are poorly understood. Current treatment strategies for cannabis cessation in FEP are clearly inefficacious. Here, we aimed to characterize the association between cannabis-related polygenic risk scores (PRS) on cannabis use and clinical course after a FEP. A cohort of 249 FEP individuals were evaluated during 12 months. Symptom severity was measured with the Positive and Negative Severity Scale and cannabis use with the EuropASI scale. Individual PRS for lifetime cannabis initiation (PRSCI) and cannabis use disorder (PRSCUD) were constructed. Current cannabis use was associated with increased positive symptoms. Cannabis initiation at younger ages conditioned the 12-month symptom progression. FEP patients with higher cannabis PRSCUD reported increased baseline cannabis use. PRSCI was associated with the course of negative and general symptomatology over follow-up. Cannabis use and symptom progression after a FEP were modulated by cannabis PRS, suggesting that lifetime initiation and use disorders may have partially independent genetic factors. These exploratory results may be the first step to identify those FEP patients more vulnerable to cannabis use and worse outcomes to ultimately develop tailored treatments.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

The role of cognitive reserve and clinical symptoms in the association between genetic liability for educational attainment and functioning in first-episode psychosis: a mediation analysis

  • Clougher, Derek
  • G Segura, Àlex
  • Forte, María Florencia
  • Mezquida, Gisela
  • Cuesta, Manuel J.
  • Vieta, Eduard
  • Amoretti, Silvia
  • Lobo, Antonio
  • González-Pinto, Ana
  • M. Díaz-Caneja, Covadonga
  • Roldán, Alexandra
  • Fico, Giovanna
  • de la Serna, Elena
  • Bergé, Daniel
  • Gassó, Patricia
  • Rodriguez, Natalia
  • Verdolini, Norma
  • Tortorella, Alfonso
  • Menculini, Giulia
  • Ribasés, Marta
  • Bernardo, Miguel
  • Mas, Sergi
Background: Polygenic risk scores for educational attainment (PRSEA), cognitive reserve (CR), and clinical symptoms are associated with psychosocial functioning in first-episode psychosis (FEP). Nevertheless, the mechanisms underlying their complex interaction is yet to be explored. This study aimed to assess the mediating role of CR and clinical symptoms, both negative (NS) and positive (PS), on the interrelationship between PRSEA and functionality, one year after a FEP. Methods: A total of 162 FEP patients underwent clinical, functional, and genetic assessments. Using genome-wide association study (GWAS) summary results, PRSEA were constructed for each individual. Two mediation models were explored. The parallel mediation model explored the relationship of PRSEA with functionality through CR and clinical symptoms, NS, and PS. The serial mediation model tested a causal chain of the three mediators: CR, NS and PS. Mediation analysis was performed using the PROCESS function V.4.1 in SPSS V.22. Results: A serial mediation model revealed a causal chain for PRSEA > CR > NS > Functionality (β=-0.35, 95%CI [-0.85, -0.04], p<0.05). The model fit the data satisfactorily (CFI=1.00; RMSEA=0.00; SRMR=7.2x10-7). Conversely, in a parallel mediation, none of the three mediators significantly mediated the relationship between PRSEA and functionality and the model poorly fit the data (CFI=0.30; RMSEA=0.25; SRMR=0.11). Conclusions: Both CR and NS mediate the relationship between PRSEA and functionality at oneyear follow-up, using serial mediation analysis. This may be relevant for prevention and personalized early intervention to reduce illness impact and improve functional outcomes in FEP patients.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Association between neutrophil to lymphocyte ratio and inflammatory biomarkers in patients with a first episode of psychosis

  • Bioque, Miquel
  • Llorca-Bofí, Vicent
  • Salmerón, Sergi
  • García-Bueno, Borja
  • MacDowell, Karina S.
  • Moreno, Carmen
  • Sáiz, Pilar A.
  • González-Pinto, Ana
  • Hidalgo-Figueroa, María
  • Barcones, María Fe
  • Rodriguez-Jimenez, Roberto
  • Bernardo, Miquel
  • Leza, Juan Carlos
Neutrophil to lymphocyte ratio (NLR) has been proposed as an emerging marker of the immune system alterations in psychotic disorders. However, it is not entirely clear whether NLR elevation is a characteristic of the psychotic disorder itself, which inflammatory pathways activation is detecting, or which possible confounding variables could alter its interpretation. We aimed to analyze the relationship of NLR values with a panel of inflammatory and oxidative/nitrosative stress biomarkers and main potential confounding factors in a well-characterized cohort of 97 patients with a first episode of psychosis (FEP) and 77 matched healthy controls (HC). In the FEP group, NLR values presented a moderate, positive correlation with the pro-inflammatory mediator Prostaglandin E2 levels (r = 0.36, p < 0.001) and a small but significant, positive correlation with cannabis use (r = 0.25, p = 0.017). After controlling for cannabis use, the association between NLR and PGE2 remained significant (beta = 0.31, p = 0.012). In the HC group, NLR values negatively correlated with body mass index (BMI, r = −0.24, p = 0.035) and positively correlated with tobacco use (r = 0.25, p = 0.031). These findings support a relationship between the elevation of NLR values and an elevated expression of proinflammatory pathways related to stress response in patients with a FEP. In addition, our study highlights the importance of considering variables such as cannabis or tobacco consumption, and BMI when interpreting the results of studies aimed to establish a clinical use of NLR. These considerations may help future research to use NLR as a reliable biomarker to determine immune system status in this population.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study

  • Amoretti, Silvia
  • Mezquida, Gisela
  • Verdolini, Norma
  • Bioque, Miquel
  • Sánchez-Torres, Ana M.
  • Pina-Camacho, Laura
  • Zorrilla, Iñaki
  • Trabsa, Amira
  • Rodríguez-Jiménez, Roberto
  • Corripio, Iluminada
  • Sarró, Salvador
  • Ibáñez, Ángela
  • Usall, Judith
  • Segarra, Rafael
  • Vieta, Eduard
  • Roberto, Natalia
  • Ramos-Quiroga, Josep Antoni
  • Tortorella, Alfonso
  • Menculini, Giulia
  • Cuesta, Manuel J.
  • Parellada, Mara
  • González-Pinto, Ana
  • Berrocoso, Esther
  • Bernardo, Miguel
  • Forte, María Florencia
  • Serra, María
  • Alonso-Solís, Anna
  • Grasa, Eva
  • Corres, Edurne García
  • Fernández Sevillano, Jessica
  • Toll, Alba
  • Martínez-Sadurní, Laura
  • Núñez-Doyle, Aggie
  • Sánchez-Pastor, Luis
  • Pomarol-Clotet, Edith
  • Guerrero-Pedraza, Amalia
  • Butjosa, Anna
  • Pardo, Marta
  • López-Ilundain, José M.
  • Ribeiro, María
  • Saiz-Ruiz, Jerónimo
  • León-Quismondo, Leticia
  • Escartí, María José
  • Contreras, Fernando
  • Cámara, Concepción de la
  • Zabala Rabadán, Arantzazu
  • Portilla, M. Paz
Introduction: Negative symptoms (NS) include asociality, avolition, anhedonia, alogia, and blunted affect and are linked to poor prognosis. It has been suggested that they reflect two different factors: diminished expression (EXP) (blunted affect and alogia) and amotivation/pleasure (MAP) (anhedonia, avolition, asociality). The aim of this article was to examine potential sex differences among first-episode schizophrenia (FES) patients and analyze sex-related predictors of two NS symptoms factors (EXP and MAP) and functional outcome. Material and methods: Two hundred and twenty-three FES (71 females and 152 males) were included and evaluated at baseline, six-months and one-year. Repeated measures ANOVA was used to examine the effects of time and sex on NS and a multiple linear regression backward elimination was performed to predict NS factors (MAP-EXP) and functioning. Results: Females showed fewer NS (p = 0.031; Cohen's d = −0.312), especially those related to EXP (p = 0.024; Cohen's d = −0.326) rather than MAP (p = 0.086), than males. In both male and female group, worse premorbid adjustment and higher depressive symptoms made a significant contribution to the presence of higher deficits in EXP at one-year follow-up, while positive and depressive symptoms predicted alterations in MAP. Finally, in females, lower deficits in MAP and better premorbid adjustment predicted better functioning at one-year follow-up (R2 = 0.494; p < 0.001), while only higher deficits in MAP predicted worse functioning in males (R2 = 0.088; p = 0.012). Conclusions: Slightly sex differences have been found in this study. Our results lead us to consider that early interventions of NS, especially those focusing on motivation and pleasure symptoms, could improve functional outcomes.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study

  • Clougher, Derek
  • Forte, María Florencia
  • Mezquida, Gisela
  • Sánchez-Torres, Ana M.
  • Serra-Navarro, María
  • Penadés, Rafael
  • Lobo, Antonio
  • González Pinto, Ana
  • Panadero, Rocío
  • Roldán, Alexandra
  • Vieta, Eduard
  • de la Serna, Elena
  • Trabsa, Amira
  • Martínez-Arán, Anabel
  • Torrent, Carla
  • Tortorella, Alfonso
  • Menculini, Giulia
  • Ramos-Quiroga, Josep Antoni
  • Cuesta, Manuel J.
  • Bernardo, Miquel
  • Amoretti, Silvia
  • Salmerón, Sergi
  • Arbelo, Néstor
  • Ferrer-Quintero, Marta
  • Echevarría, Ana
  • Selma, Judit
  • Grasa, Eva Ma
  • Marin, Julen
  • Mar, Lorea
  • De la Cámara, Concepción
  • Ruíz-Lázaro, Pedro M
  • Nacher, Juan
  • Nicolas, Carlos Cañete
  • Mané, Anna
  • Toll, Alba
  • Solé, Brisa
  • Mallorqui, Aida
  • Castro-Fornieles, Josefina
  • Baeza, Inmaculada
  • Contreras, Fernando
  • Sáiz, Pilar A.
  • Bobes-Bascarán, Teresa
  • Segarra, Rafael
  • Zabala, Arantzazu
  • Scala, Mauro
  • Rodriguez-Jimenez, Roberto
  • Usall, Judith
  • Butjosa, Anna
  • Pomarol-Clotet, Edith
  • García-León, Maria Ángeles
  • Ibañez, Angela
  • Moreno-Izco, Lucía
  • Balanzá-Martínez, Vicent
Emotional intelligence (EI) and neurocognition (NC) impairments are common in first-episode psychosis (FEP), yet their evolution over time remains unclear. This study identified patient profiles in EI and NC performance in FEP. 98 adult FEP patients and 128 healthy controls (HCs) were tested on clinical, functional, EI, and NC variables at baseline and two-year follow-up (FUP). A repeated-measures ANOVA compared the effects of group (patients and HCs) and time on EI. Significant EI improvements were observed in both groups. Four groups were created based on NC and EI performance at baseline and FUP in patients: impairment in NC and EI, impairment in NC only, impairment in EI only, and no impairment. At FUP, patients impaired in NC and EI showed less cognitive reserve (CR), greater negative and positive symptoms, and poorer functional outcomes. At FUP, three group trajectories were identified: (I) maintain dual impairment (II) maintain no impairment or improve, (III) maintain sole impairment or worsen. The maintain dual impairment group had the lowest levels of CR. EI and NC impairments progress differently in FEP. Greater CR may protect against comorbid EI/NC impairment. Identifying these patient characteristics could contribute to the development of personalised interventions.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Sex matters: Differences in prodromes, clinical and neuropsychological features in individuals with a first episode mania or psychosis

  • Torrent Font, Carla
  • Fares-Otero, Natalia E.
  • Palacios Garrán, Roberto
  • Serra-Navarro, Maria
  • Garriga, Marina
  • Amoretti, Silvia
  • Ramos-Quiroga, Josep Antoni
Early psychosis; Prodromes; Sex differences, Psicosis temprana; Pródromos; Diferencias de sexo, Psicosi primerenca; Pròdroms; Diferències de sexe, Objective This study was aimed at identifying sex differences in patients presenting a first episode mania (FEM) or psychosis (FEP) to help shaping early treatment strategies focused on sex differences. Methods Patients with a FEM or FEP underwent a clinical, neuropsychological (neurocognitive functions and emotional intelligence) and functional assessment. Performance on those variables was compared between groups through general linear model, with sex and group (FEM vs FEP) as main effects and group by sex interactions. Results The total sample included 113 patients: FEM = 72 (45.83 % females) and FEP = 41 (46.34 % females). There were significant main effects for group (not for sex) for most of the clinical features (depressive, negative and positive symptoms) and psychosocial functioning (χ2 = 8.815, p = 0.003). As for neuropsychological performance, there were significant main effects for sex and group. Females performed better than males in verbal memory (χ2 = 9.038, p = 0.003) and obtained a higher emotional intelligence quotient (χ2 = 13.20, p < 0.001). On the contrary, males obtained better results in working memory (χ2 = 7.627, p = 0.006). FEP patients significantly underperformed FEM patients in most cognitive domains. There were significant group by sex interactions for few neuropsychological variables, namely processing speed (χ2 = 4.559, p = 0.033) and verbal fluency (χ2 = 8.913, p = 0.003). Limitations Differences between sexes were evaluated, but the influence of gender was not considered. Retrospective evaluation of prodromes and substance use. No healthy control group comparator. Conclusion The main finding is the presence of significant sex effect and group by sex interaction on specific neurocognitive cognition and emotional intelligence measures. Tailored sex-based early treatment strategies might be implemented., This work was supported by The Secretaria d’ Universitats i Recerca del Departament d'Economia i Coneixement (2021 SGR 01128; 2017-SGR-1271); the CIBER -Consorcio Centro de Investigación Biomédica en Red (CIBERSAM), Instituto de Salud Carlos III; the Centres de Recerca de Catalunya-CERCA Programme; the Spanish Ministry of Science, Innovation (CPII16/00018 to EPC, CD20/00177 to SA, PI24/00671 to SA, PI12/0091 to EV, PI15/00283 to EV, PI18/00805 to EV, PI21/00787 to EV, PI24/00432 to EV and AMA, PI18/01001 to IP, PI20/00344 to CT, PI24/00407 to CT) integrated into the Plan Nacional de I + D + I and co-financed by the ISCIII-Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER); the Instituto de Salud Carlos III; the “Pla estrategic de Recerca i Innovació en Salut 2016–2020” (SLT006/17/00357 to EV); the La Marató-TV3 Foundation grants 202234–30 (to EV) and 202234–32 (to SA); the Biomedicine international training research programme for excellent clinician-scientists-BITRECS project (Marie-Curie grant No 754550 and “La Caixa” Foundation LCF/PR/GN18/50310006 to NV). SA has been supported by Sara Borrell doctoral programme (CD20/00177) and M-AES mobility fellowship (MV22/00002), from the Instituto de Salud Carlos III (ISCIII), and co-funded by European Social Fund “Investing in your future”. MFF received the support of “Contratos predoctorales de formación en investigación en salud” (PFIS22) (FI22/00185) from the Instituto de Salud Carlos III (ISCIII). NEF-O thanks the support of the European Union Horizon 2020 research and innovation program (EU.3.1.3. Treating and managing disease: Grant No 945151), and DAAD (Deutscher Akademischer Austauschdienst) (ID-57681229 - Ref. No. 91629413).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Obstetric complications and psychopathology in schizophrenia: A systematic review and meta-analysis

  • Forte, Maria Florencia
  • Oliva, Vincenzo
  • De Prisco, Michele
  • Garriga, Marina
  • Bitanihirwe, Byron
  • Alameda, Luis
  • Amoretti, Silvia
  • Ramos-Quiroga, Josep Antoni
Obstetric complications; Psychopathology; Schizophrenia, Complicaciones obstétricas; Psicopatología; Esquizofrenia, Complicacions obstètriques; Psicopatologia; Esquizofrènia, Schizophrenia (SZ) is a severe mental health condition involving gene-environment interactions, with obstetric complications (OCs) conferring an elevated risk for the disease. Current research suggests that OCs may exacerbate SZ symptoms. This study conducted a systematic review and meta-analysis to comprehensively evaluate differences in psychopathology between individuals with and without exposure to OCs in relation to SZ and related disorders. We systematically searched PubMed, PsycINFO, and SCOPUS to identify eligible studies. A total of 4091 records were retrieved through systematic and citation searches. 14 studies were included in the review, and 12 met the criteria for meta-analysis, involving 2992 patients. The analysis revealed that SZ patients who had been exposed to OCs exhibited significantly higher levels of positive symptoms (SMD=0.10, 95 %CI=0.01,0.20; p=0.03), general psychopathology (SMD=0.37, 95 %CI=0.22,0.52; p<0.001), total clinical symptomatology (SMD=0.44, 95 %CI=0.24,0.64; p<0.001) and depressive symptoms (SMD=0.47, 95 %CI=0.09,0.84; p=0.01). No significant differences were found in negative symptomatology and functioning. Our results suggest that OCs are not only associated with an increased risk of developing psychosis but with more severe symptomatology., This study is part of the project PI20/00661 (C. García-Rizo) and PI24/00196 (C. Garcia-Rizo and G. Mezquida) funded by the Carlos III Health Institute (ISCIII) and co-financed by the European Union, Centro de Investigación Biomédica en Red de salud Mental, CIBERSAM, CERCA Program / Generalitat de Catalunya And Secretaria d′Universitats i Recerca del Departament d′Economia I Coneixement (2017SGR1355). G. Mezquida is a Serra Húnter Fellow, within the Tenure-elegible Lecturer Serra Hunter program (UB-LE-212–024, Generalitat de Catalunya). M. F. Forte received the support of “Contratos predoctorales de formación en investigación en salud" (PFIS22) (FI22/00185) from the Instituto de Salud Carlos III (ISCIII) with European funds from the Recovery, Transformation and Resilience Plan, by virtue of the Resolution of the Directorate of the Carlos III Health Institute, O.A., M.P. of December 14, 2022, granting Predoctoral Research Training Contracts in Health (PFIS Contracts). Funded by the European Union NextGenerationEU. S. Amoretti has been supported by Sara Borrell doctoral programme (CD20/00177) and M-AES mobility fellowship (MV22/00002), from the Instituto de Salud Carlos III (ISCIII), and co-funded by European Social Fund “Investing in your future”. E. Vieta thanks the support of the Spanish Ministry of Science, Innovation and Universities (PI18/00805; PI21/00787) integrated into the Plan Nacional de I+D+I and co-financed by ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER); CIBERSAM; and the Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya to the Bipolar Disorders Group (2021 SGR 1358) and the project SLT006/17/00357, from PERIS 2016–2020 (Departament de Salut). CERCA Programme/Generalitat de Catalunya. M. Garriga thanks the support of the Spanish Ministry of Science, Innovation and Universities (PI21/00340) integrated into the Plan Nacional de I+D+I and co-financed by ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER); CIBERSAM; and the Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya to the Bipolar Disorders Group (2021 SGR 1358). CERCA Programme/Generalitat de Catalunya. J.A. Ramos-Quiroga thanks the suport of the CIBERSAM; Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya to the Psychiatry, Mental Health and Addictions Group (2021 SGR 00840). I. Baeza thanks the Spanish Ministry of Science, Innovation and Universities and Instituto de Salud Carlos III (PI21/0391) co-funded by the European Union, the National Drugs Plan (2022 I053) and Fundación Alicia Koplowitz., We would like to thank the Carlos III Healthcare Institute, the Spanish Ministry of Science, Innovation and Universities, the European Regional Development Fund (ERDF/FEDER) (PI08/0208, PI11/00325, PI14/00612, PI14/00753, PI20/00661, and PI24/00196); CIBERSAM; CERCA Program; Government of Catalonia, the Secretariat of Universities and Research of the Department of Enterprise and Knowledge (2021 SGR 01120), the Institut de Neurociències, Universitat de Barcelona, UBNeuro, and the Serra-Hunter Programme, Government of Catalonia. This work was also supported by La Marató-TV3 Foundation grants 202234–32 (to S. Amoretti); 202234–30 (to E. Vieta); 202234–30 (to A. Gonzàlez-Segura), 202225–30 (to R. Penadés). IB thanks Pons Bartran legacy (FCRB_IPB2–2023), and CGR thanks the Maria i Nuria Cunillera legacy (FCRB_CU1_2024) for the support.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study

  • Clougher, Derek
  • Mezquida Mateos, Gisela
  • Sánchez-Torres, Ana Maria
  • Serra-Navarro, Maria
  • Penadés , Rafael
  • Forte, Maria Florencia
  • Amoretti, Silvia
  • Ramos-Quiroga, Josep Antoni
Emotional intelligence; Emotional processing; Neurocognition, Inteligencia emocional; Procesamiento emocional; Neurocognición, Intel·ligència emocional; Processament emocional; Neurocognició, Emotional intelligence (EI) and neurocognition (NC) impairments are common in first-episode psychosis (FEP), yet their evolution over time remains unclear. This study identified patient profiles in EI and NC performance in FEP. 98 adult FEP patients and 128 healthy controls (HCs) were tested on clinical, functional, EI, and NC variables at baseline and two-year follow-up (FUP). A repeated-measures ANOVA compared the effects of group (patients and HCs) and time on EI. Significant EI improvements were observed in both groups. Four groups were created based on NC and EI performance at baseline and FUP in patients: impairment in NC and EI, impairment in NC only, impairment in EI only, and no impairment. At FUP, patients impaired in NC and EI showed less cognitive reserve (CR), greater negative and positive symptoms, and poorer functional outcomes. At FUP, three group trajectories were identified: (I) maintain dual impairment (II) maintain no impairment or improve, (III) maintain sole impairment or worsen. The maintain dual impairment group had the lowest levels of CR. EI and NC impairments progress differently in FEP. Greater CR may protect against comorbid EI/NC impairment. Identifying these patient characteristics could contribute to the development of personalised interventions., This study is part of a coordinated-multicentre Project, funded by the Ministerio de Economía y Competitividad (PI08/0208; PI11/00325; PI14/00612), Instituto de Salud Carlos III – Fondo Europeo de Desarrollo Regional. Unión Europea. Una manera de hacer Europa, Centro de Investigación Biomédica en Red de salud Mental, CIBERSAM, by the CERCA Programme / Generalitat de Catalunya AND Secretaria d'Universitats i Recerca del Departament d'Economia I Coneixement (2021 SGR 01120). Departament de Salut de la Generalitat de Catalunya, en la convocatòria corresponent a l'any 2017 de concessió de subvencions del Pla Estratègic de Recerca i Innovació en Salut (PERIS) 2016-2020, modalitat Projectes de recerca orientats a l'atenció primària, amb el codi d'expedient SLT006/17/00345. This work was supported by La Marató-TV3 Foundation grants 202234-30 (to E. Vieta), 202234-32 (to S. Amoretti). S. Amoretti has been supported by Sara Borrell doctoral programme (CD20/00177) and M-AES mobility fellowship (MV22/00002), from the Instituto de Salud Carlos III (ISCIII), and co-funded by European Social Fund “Investing in your future”. MFF received the support of “Contratos predoctorales de formación en investigación en salud" (PFIS22) (FI22/00185) from the Instituto de Salud Carlos III (ISCIII) with European funds from the Recovery, Transformation and Resilience Plan, by virtue of the Resolution of the Directorate of the Carlos III Health Institute, O.A., M.P. of December 14, 2022, granting Predoctoral Research Training Contracts in Health (PFIS Contracts). Funded by the European Union – tGenerationEU. E. Vieta thanks the support of the Spanish Ministry of Science, Innovation and Universities (PI18/00805; PI21/00787) integrated into the Plan Nacional de I+D+I y cofinanciado por el ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER); CIBERSAM; and the Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya to the Bipolar Disorders Group (2021 SGR 1358) and the project SLT006/17/00357, from PERIS 2016-2020 (Departament de Salut). CERCA Programme/Generalitat de Catalunya. A. González-Pinto thanks the support of the Spanish Ministry of Science, Innovation and Universities PI21/00713, PI18/01055 integrated into the Plan Nacional de I+D+I y cofinanciado por el ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER); CIBERSAM; and the Basque Government 2022111054. C. Torrent thanks the support of the Spanish Ministry of Science, Innovation and Universities (PI20/00344) integrated into the Plan Nacional de I+D+I y cofinanciado por el ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Sex differences in the efficacy of cognitive behavioral therapy for adults with attention-deficit/hyperactivity disorder

  • Biel, Santiago
  • Mestres-Ferrés, Ferran
  • Ramos Sayalero, Carolina
  • Fadeuilhe, Christian
  • Crespín Hombrao, Juan Jesús
  • Corrales, Montserrat
  • Richarte, Vanesa
  • Parramon Puig, Gemma
  • Ibáñez-Jiménez, Pol
  • Nieva, Gemma
  • Amoretti, Silvia
  • Ramos-Quiroga, Josep Antoni
ADHD; Cognitive behavioral therapy; Sex differences, TDAH; Teràpia cognitivo-conductual; Diferències sexuals, TDAH; Terapia cognitivo-conductual; Diferencias sexuals, Background and objectives Cognitive Behavioral Therapy (CBT) is an effective adjunctive treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). This study examined sex differences in the efficacy of a brief 6-session CBT program versus a traditional 12-session format, combined with stable pharmacotherapy, in adults with ADHD. Methods A total of 81 adults (58 % male; 41.27 ± 9.26 years) were randomly assigned to 6- or 12-session CBT. ADHD symptoms, psychopathology, and functioning were assessed at baseline, post-treatment, and 3- and 6-month follow-up. Mixed-effects models analyzed interactions between time, treatment group, and sex. Results At baseline, females exhibited greater symptom severity (p = 0.019), higher inattention (p < 0.001), and more pronounced impairments (p = 0.004). CBT led to significant clinical improvements regardless of sex. A significant time-by-sex interaction emerged for inattention (CAARS:O:L, p = 0.043), although it did not remain significant after adjusting for baseline severity. Regarding time × group × sex interactions, females in the 6-session group showed smaller reductions in clinical severity during follow-up (CGI-S, p = 0.047); however, this effect was no longer statistically significant after controlling for baseline ADHD severity. Findings should be interpreted with caution given the limited female sample at follow-up and the significant influence of initial symptom burden on long-term trajectories. Conclusions CBT improves ADHD symptoms and related impairments in adults, with comparable overall benefits across sexes. Treatment response follow-up differences were better explained by baseline severity and treatment intensity rather than sex-specific differences., This research was supported by the Generalitat de Catalunya, Departament de Recerca i Universitats, through the Comissionat per a Universitats i Recerca (SGR grant 2021 SGR 00840). Dr. Amoretti (PI24/00671) and Dr. Torrent (PI20/00344; PI24/00407) thank the support of the Spanish Ministry of Innovation and Science, funded by the Instituto de Salud Carlos III and cofinanced by the European Union (FEDER) “Una manera de hacer Europa”. Dr. Amoretti has been supported by Sara Borrell doctoral programme (CD20/00177) and M-AES mobility fellowship (MV22/00002), from the Instituto de Salud Carlos III (ISCIII), and co-funded by European Social Fund “Investing in your future” and La Marató-TV3 Foundation grants 202234-32. Dr. Ramos-Quiroga was also supported by the European Union H2020 Programme (H2020/2014–2020) under grant agreement no. 848228 (DISCOvERIE).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Role of Premorbid IQ and Age of Onset as Useful Predictors of Clinical, Functional Outcomes, and Recovery of Individuals with a First Episode of Psychosis

  • Molina-García, Mariola
  • Fraguas, David|||0000-0002-7931-2933
  • del Rey-Mejías, Ángel|||0000-0003-1690-3215
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Sánchez Torres, Ana Maria|||0000-0002-9505-2406
  • Amoretti, Silvia|||0000-0001-6017-2734
  • Lobo, Antonio|||0000-0002-9098-655X
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Andreu-Bernabeu, Álvaro
  • Corripio, Iluminada|||0000-0003-2562-711X
  • Vieta, Eduard|||0000-0002-0548-0053
  • Baeza, Inmaculada|||0000-0003-2611-5781
  • Mané, Anna|||0000-0003-2127-349X
  • Cuesta, Manuel J.|||0000-0003-0250-5718
  • de la Serna, Elena|||0000-0002-7869-9881
  • Payá, Beatriz
  • Zorrilla, Iñaki|||0000-0001-6444-8208
  • Arango, Celso|||0000-0003-3382-4754
  • Bernardo, Miquel|||0000-0001-8748-6717
  • Rapado-Castro, Marta|||0000-0001-8484-6051
  • Parellada, Mara|||0000-0001-7977-3601
Background: premorbid IQ (pIQ) and age of onset are predictors of clinical severity and long-term functioning after a first episode of psychosis. However, the additive influence of these variables on clinical, functional, and recovery rates outcomes is largely unknown. Methods: we characterized 255 individuals who have experienced a first episode of psychosis in four a priori defined subgroups based on pIQ (low pIQ < 85; average pIQ ≥ 85) and age of onset (early onset < 18 years; adult onset ≥ 18 years). We conducted clinical and functional assessments at baseline and at two-year follow-up. We calculated symptom remission and recovery rates using the Positive and Negative Symptoms of Schizophrenia Schedule (PANSS) and the Global Assessment Functioning (GAF or Children-GAF). We examined clinical and functional changes with pair-wise comparisons and two-way mixed ANOVA. We built hierarchical lineal and logistic regression models to estimate the predictive value of the independent variables over functioning or recovery rates. Results: early-onset patients had more severe positive symptoms and poorer functioning than adult-onset patients. At two-year follow-up, only early-onset with low pIQ and adult-onset with average pIQ subgroups differed consistently, with the former having more negative symptoms (d = 0.59), poorer functioning (d = 0.82), lower remission (61% vs. 81.1%), and clinical recovery (34.1% vs. 62.2%). Conclusions: early-onset individuals with low pIQ may present persistent negative symptoms, lower functioning, and less recovery likelihood at two-year follow-up. Intensive cognitive and functional programs for these individuals merit testing to improve long-term recovery rates in this subgroup.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years

  • Verdolini, Norma|||0000-0001-9488-2881
  • Amoretti, Silvia|||0000-0001-6017-2734
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Cuesta, Manuel J.|||0000-0003-0250-5718
  • Pina-Camacho, Laura|||0000-0003-1960-6443
  • Garcia Rizo, Clemente|||0000-0002-4855-1608
  • Lobo, Antonio|||0000-0002-9098-655X
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Merchán-Naranjo, Jessica
  • Corripio, Iluminada|||0000-0003-2562-711X
  • Salagre, Estela|||0000-0001-6352-5179
  • Baeza, Inmaculada|||0000-0003-2611-5781
  • Bergé Baquero, Daniel|||0000-0003-2544-1016
  • Garriga, Marina|||0000-0001-7312-4969
  • Bioque, Miquel|||0000-0001-6887-7149
  • Vallespir, Catalina
  • Serra-Navarro, Maria|||0000-0002-9736-4630
  • Vieta, Eduard|||0000-0002-0548-0053
  • Bernardo, Miquel|||0000-0001-8748-6717
The aim of the present study was to evaluate the contribution of family environment styles and psychiatric family history on functioning of patients presenting first-episode psychosis (FEP). Patients with FEP and healthy controls (HC) were assessed at baseline and after 2 years. The Functional Assessment Short Test (FAST) was used to assess functional outcome and the Family Environment Scale (FES) to evaluate family environment. Linear regressions evaluated the effect that family environment exerts on functioning at baseline and at 2-year follow-up, when FEP patients were diagnosed according to non-affective (NA-PSYCH) or affective psychoses (A-PSYCH). The influence of a positive parents' psychiatric history on functioning was evaluated through one-way between-groups analysis of covariance (ANCOVA) models, after controlling for family environmental styles. At baseline, FEP patients presented moderate functioning impairment, significantly worse than HC (28.65±16.17 versus 3.25±7.92; p<0.001, g = 1.91). At 2-year follow-up, the functioning of NA-PSYCH patients was significantly worse than in A-PSYCH (19.92±14.83 versus 12.46±14.86; p = 0.020, g = 0.50). No specific family environment style was associated with functioning in FEP patients and HC. On the contrary, a positive psychiatric father's history influenced functioning of FEP patients. After 2 years, worse functioning in NA-PSYCH patients was associated with lower rates of active-recreational and achievement orientated family environment and with higher rates of moral-religious emphasis and control. In A-PSYCH, worse functioning was associated with higher rates of conflict in the family. Both family environment and psychiatric history influence psychosocial functioning, with important implications for early interventions, that should involve both patients and caregivers.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Identifying clinical clusters with distinct trajectories in first-episode psychosis through an unsupervised machine learning technique

  • Amoretti, Silvia|||0000-0001-6017-2734
  • Verdolini, Norma|||0000-0001-9488-2881
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Rabelo-da-Ponte, Francisco Diego|||0000-0001-9016-2414
  • Cuesta, Manuel J.|||0000-0003-0250-5718
  • Pina-Camacho, Laura|||0000-0003-1960-6443
  • Gomez-Ramiro, Marta|||0000-0002-3463-0866
  • Cámara, Concepción de la|||0000-0003-2284-7862
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Díaz-Caneja, Covadonga M.|||0000-0001-8538-3175
  • Corripio, Iluminada|||0000-0003-2562-711X
  • Vieta, Eduard|||0000-0002-0548-0053
  • de la Serna, Elena|||0000-0002-7869-9881
  • Mané, Anna|||0000-0003-2127-349X
  • Solé, Brisa|||0000-0003-1673-8248
  • Carvalho, André F.
  • Serra-Navarro, Maria|||0000-0002-9736-4630
  • Bernardo, Miquel|||0000-0001-8748-6717
The extreme variability in symptom presentation reveals that individuals diagnosed with a first-episode psychosis (FEP) may encompass different sub-populations with potentially different illness courses and, hence, different treatment needs. Previous studies have shown that sociodemographic and family environment factors are associated with more unfavorable symptom trajectories. The aim of this study was to examine the dimensional structure of symptoms and to identify individuals' trajectories at early stage of illness and potential risk factors associated with poor outcomes at follow-up in non-affective FEP. One hundred and forty-four non-affective FEP patients were assessed at baseline and at 2-year follow-up. A Principal component analysis has been conducted to identify dimensions, then an unsupervised machine learning technique (fuzzy clustering) was performed to identify clinical subgroups of patients. Six symptom factors were extracted (positive, negative, depressive, anxiety, disorganization and somatic/cognitive). Three distinct clinical clusters were determined at baseline: mild; negative and moderate; and positive and severe symptoms, and five at follow-up: minimal; mild; moderate; negative and depressive; and severe symptoms. Receiving a low-dose antipsychotic, having a more severe depressive symptomatology and a positive family history for psychiatric disorders were risk factors for poor recovery, whilst having a high cognitive reserve and better premorbid adjustment may confer a better prognosis. The current study provided a better understanding of the heterogeneous profile of FEP. Early identification of patients who could likely present poor outcomes may be an initial step for the development of targeted interventions to improve illness trajectories and preserve psychosocial functioning.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Sex matters: Differences in prodromes, clinical and neuropsychological features in individuals with a first episode mania or psychosis

  • Torrent Font, Carla
  • Fares-Otero, Natalia E.
  • Palacios Garrán, Roberto
  • Serra-Navarro, Maria
  • Garriga, Marina
  • Amoretti, Silvia
  • Ramos-Quiroga, Josep Antoni
Early psychosis; Prodromes; Sex differences, Psicosis temprana; Pródromos; Diferencias de sexo, Psicosi primerenca; Pròdroms; Diferències de sexe, Objective This study was aimed at identifying sex differences in patients presenting a first episode mania (FEM) or psychosis (FEP) to help shaping early treatment strategies focused on sex differences. Methods Patients with a FEM or FEP underwent a clinical, neuropsychological (neurocognitive functions and emotional intelligence) and functional assessment. Performance on those variables was compared between groups through general linear model, with sex and group (FEM vs FEP) as main effects and group by sex interactions. Results The total sample included 113 patients: FEM = 72 (45.83 % females) and FEP = 41 (46.34 % females). There were significant main effects for group (not for sex) for most of the clinical features (depressive, negative and positive symptoms) and psychosocial functioning (χ2 = 8.815, p = 0.003). As for neuropsychological performance, there were significant main effects for sex and group. Females performed better than males in verbal memory (χ2 = 9.038, p = 0.003) and obtained a higher emotional intelligence quotient (χ2 = 13.20, p < 0.001). On the contrary, males obtained better results in working memory (χ2 = 7.627, p = 0.006). FEP patients significantly underperformed FEM patients in most cognitive domains. There were significant group by sex interactions for few neuropsychological variables, namely processing speed (χ2 = 4.559, p = 0.033) and verbal fluency (χ2 = 8.913, p = 0.003). Limitations Differences between sexes were evaluated, but the influence of gender was not considered. Retrospective evaluation of prodromes and substance use. No healthy control group comparator. Conclusion The main finding is the presence of significant sex effect and group by sex interaction on specific neurocognitive cognition and emotional intelligence measures. Tailored sex-based early treatment strategies might be implemented., This work was supported by The Secretaria d’ Universitats i Recerca del Departament d'Economia i Coneixement (2021 SGR 01128; 2017-SGR-1271); the CIBER -Consorcio Centro de Investigación Biomédica en Red (CIBERSAM), Instituto de Salud Carlos III; the Centres de Recerca de Catalunya-CERCA Programme; the Spanish Ministry of Science, Innovation (CPII16/00018 to EPC, CD20/00177 to SA, PI24/00671 to SA, PI12/0091 to EV, PI15/00283 to EV, PI18/00805 to EV, PI21/00787 to EV, PI24/00432 to EV and AMA, PI18/01001 to IP, PI20/00344 to CT, PI24/00407 to CT) integrated into the Plan Nacional de I + D + I and co-financed by the ISCIII-Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER); the Instituto de Salud Carlos III; the “Pla estrategic de Recerca i Innovació en Salut 2016–2020” (SLT006/17/00357 to EV); the La Marató-TV3 Foundation grants 202234–30 (to EV) and 202234–32 (to SA); the Biomedicine international training research programme for excellent clinician-scientists-BITRECS project (Marie-Curie grant No 754550 and “La Caixa” Foundation LCF/PR/GN18/50310006 to NV). SA has been supported by Sara Borrell doctoral programme (CD20/00177) and M-AES mobility fellowship (MV22/00002), from the Instituto de Salud Carlos III (ISCIII), and co-funded by European Social Fund “Investing in your future”. MFF received the support of “Contratos predoctorales de formación en investigación en salud” (PFIS22) (FI22/00185) from the Instituto de Salud Carlos III (ISCIII). NEF-O thanks the support of the European Union Horizon 2020 research and innovation program (EU.3.1.3. Treating and managing disease: Grant No 945151), and DAAD (Deutscher Akademischer Austauschdienst) (ID-57681229 - Ref. No. 91629413).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study

  • Clougher, Derek
  • Mezquida Mateos, Gisela
  • Sánchez-Torres, Ana Maria
  • Serra-Navarro, Maria
  • Penadés , Rafael
  • Forte, Maria Florencia
  • Amoretti, Silvia
  • Ramos-Quiroga, Josep Antoni
Emotional intelligence; Emotional processing; Neurocognition, Inteligencia emocional; Procesamiento emocional; Neurocognición, Intel·ligència emocional; Processament emocional; Neurocognició, Emotional intelligence (EI) and neurocognition (NC) impairments are common in first-episode psychosis (FEP), yet their evolution over time remains unclear. This study identified patient profiles in EI and NC performance in FEP. 98 adult FEP patients and 128 healthy controls (HCs) were tested on clinical, functional, EI, and NC variables at baseline and two-year follow-up (FUP). A repeated-measures ANOVA compared the effects of group (patients and HCs) and time on EI. Significant EI improvements were observed in both groups. Four groups were created based on NC and EI performance at baseline and FUP in patients: impairment in NC and EI, impairment in NC only, impairment in EI only, and no impairment. At FUP, patients impaired in NC and EI showed less cognitive reserve (CR), greater negative and positive symptoms, and poorer functional outcomes. At FUP, three group trajectories were identified: (I) maintain dual impairment (II) maintain no impairment or improve, (III) maintain sole impairment or worsen. The maintain dual impairment group had the lowest levels of CR. EI and NC impairments progress differently in FEP. Greater CR may protect against comorbid EI/NC impairment. Identifying these patient characteristics could contribute to the development of personalised interventions., This study is part of a coordinated-multicentre Project, funded by the Ministerio de Economía y Competitividad (PI08/0208; PI11/00325; PI14/00612), Instituto de Salud Carlos III – Fondo Europeo de Desarrollo Regional. Unión Europea. Una manera de hacer Europa, Centro de Investigación Biomédica en Red de salud Mental, CIBERSAM, by the CERCA Programme / Generalitat de Catalunya AND Secretaria d'Universitats i Recerca del Departament d'Economia I Coneixement (2021 SGR 01120). Departament de Salut de la Generalitat de Catalunya, en la convocatòria corresponent a l'any 2017 de concessió de subvencions del Pla Estratègic de Recerca i Innovació en Salut (PERIS) 2016-2020, modalitat Projectes de recerca orientats a l'atenció primària, amb el codi d'expedient SLT006/17/00345. This work was supported by La Marató-TV3 Foundation grants 202234-30 (to E. Vieta), 202234-32 (to S. Amoretti). S. Amoretti has been supported by Sara Borrell doctoral programme (CD20/00177) and M-AES mobility fellowship (MV22/00002), from the Instituto de Salud Carlos III (ISCIII), and co-funded by European Social Fund “Investing in your future”. MFF received the support of “Contratos predoctorales de formación en investigación en salud" (PFIS22) (FI22/00185) from the Instituto de Salud Carlos III (ISCIII) with European funds from the Recovery, Transformation and Resilience Plan, by virtue of the Resolution of the Directorate of the Carlos III Health Institute, O.A., M.P. of December 14, 2022, granting Predoctoral Research Training Contracts in Health (PFIS Contracts). Funded by the European Union – tGenerationEU. E. Vieta thanks the support of the Spanish Ministry of Science, Innovation and Universities (PI18/00805; PI21/00787) integrated into the Plan Nacional de I+D+I y cofinanciado por el ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER); CIBERSAM; and the Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya to the Bipolar Disorders Group (2021 SGR 1358) and the project SLT006/17/00357, from PERIS 2016-2020 (Departament de Salut). CERCA Programme/Generalitat de Catalunya. A. González-Pinto thanks the support of the Spanish Ministry of Science, Innovation and Universities PI21/00713, PI18/01055 integrated into the Plan Nacional de I+D+I y cofinanciado por el ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER); CIBERSAM; and the Basque Government 2022111054. C. Torrent thanks the support of the Spanish Ministry of Science, Innovation and Universities (PI20/00344) integrated into the Plan Nacional de I+D+I y cofinanciado por el ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Sex differences in the efficacy of cognitive behavioral therapy for adults with attention-deficit/hyperactivity disorder

  • Biel, Santiago
  • Mestres-Ferrés, Ferran
  • Ramos Sayalero, Carolina
  • Fadeuilhe, Christian
  • Crespín Hombrao, Juan Jesús
  • Corrales, Montserrat
  • Richarte, Vanesa
  • Parramon Puig, Gemma
  • Ibáñez-Jiménez, Pol
  • Nieva, Gemma
  • Amoretti, Silvia
  • Ramos-Quiroga, Josep Antoni
ADHD; Cognitive behavioral therapy; Sex differences, TDAH; Teràpia cognitivo-conductual; Diferències sexuals, TDAH; Terapia cognitivo-conductual; Diferencias sexuals, Background and objectives Cognitive Behavioral Therapy (CBT) is an effective adjunctive treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). This study examined sex differences in the efficacy of a brief 6-session CBT program versus a traditional 12-session format, combined with stable pharmacotherapy, in adults with ADHD. Methods A total of 81 adults (58 % male; 41.27 ± 9.26 years) were randomly assigned to 6- or 12-session CBT. ADHD symptoms, psychopathology, and functioning were assessed at baseline, post-treatment, and 3- and 6-month follow-up. Mixed-effects models analyzed interactions between time, treatment group, and sex. Results At baseline, females exhibited greater symptom severity (p = 0.019), higher inattention (p < 0.001), and more pronounced impairments (p = 0.004). CBT led to significant clinical improvements regardless of sex. A significant time-by-sex interaction emerged for inattention (CAARS:O:L, p = 0.043), although it did not remain significant after adjusting for baseline severity. Regarding time × group × sex interactions, females in the 6-session group showed smaller reductions in clinical severity during follow-up (CGI-S, p = 0.047); however, this effect was no longer statistically significant after controlling for baseline ADHD severity. Findings should be interpreted with caution given the limited female sample at follow-up and the significant influence of initial symptom burden on long-term trajectories. Conclusions CBT improves ADHD symptoms and related impairments in adults, with comparable overall benefits across sexes. Treatment response follow-up differences were better explained by baseline severity and treatment intensity rather than sex-specific differences., This research was supported by the Generalitat de Catalunya, Departament de Recerca i Universitats, through the Comissionat per a Universitats i Recerca (SGR grant 2021 SGR 00840). Dr. Amoretti (PI24/00671) and Dr. Torrent (PI20/00344; PI24/00407) thank the support of the Spanish Ministry of Innovation and Science, funded by the Instituto de Salud Carlos III and cofinanced by the European Union (FEDER) “Una manera de hacer Europa”. Dr. Amoretti has been supported by Sara Borrell doctoral programme (CD20/00177) and M-AES mobility fellowship (MV22/00002), from the Instituto de Salud Carlos III (ISCIII), and co-funded by European Social Fund “Investing in your future” and La Marató-TV3 Foundation grants 202234-32. Dr. Ramos-Quiroga was also supported by the European Union H2020 Programme (H2020/2014–2020) under grant agreement no. 848228 (DISCOvERIE).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Obstetric complications and psychopathology in schizophrenia: A systematic review and meta-analysis

  • Forte, Maria Florencia
  • Oliva, Vincenzo
  • De Prisco, Michele
  • Garriga, Marina
  • Bitanihirwe, Byron
  • Alameda, Luis
  • Amoretti, Silvia
  • Ramos-Quiroga, Josep Antoni
Obstetric complications; Psychopathology; Schizophrenia, Complicaciones obstétricas; Psicopatología; Esquizofrenia, Complicacions obstètriques; Psicopatologia; Esquizofrènia, Schizophrenia (SZ) is a severe mental health condition involving gene-environment interactions, with obstetric complications (OCs) conferring an elevated risk for the disease. Current research suggests that OCs may exacerbate SZ symptoms. This study conducted a systematic review and meta-analysis to comprehensively evaluate differences in psychopathology between individuals with and without exposure to OCs in relation to SZ and related disorders. We systematically searched PubMed, PsycINFO, and SCOPUS to identify eligible studies. A total of 4091 records were retrieved through systematic and citation searches. 14 studies were included in the review, and 12 met the criteria for meta-analysis, involving 2992 patients. The analysis revealed that SZ patients who had been exposed to OCs exhibited significantly higher levels of positive symptoms (SMD=0.10, 95 %CI=0.01,0.20; p=0.03), general psychopathology (SMD=0.37, 95 %CI=0.22,0.52; p<0.001), total clinical symptomatology (SMD=0.44, 95 %CI=0.24,0.64; p<0.001) and depressive symptoms (SMD=0.47, 95 %CI=0.09,0.84; p=0.01). No significant differences were found in negative symptomatology and functioning. Our results suggest that OCs are not only associated with an increased risk of developing psychosis but with more severe symptomatology., This study is part of the project PI20/00661 (C. García-Rizo) and PI24/00196 (C. Garcia-Rizo and G. Mezquida) funded by the Carlos III Health Institute (ISCIII) and co-financed by the European Union, Centro de Investigación Biomédica en Red de salud Mental, CIBERSAM, CERCA Program / Generalitat de Catalunya And Secretaria d′Universitats i Recerca del Departament d′Economia I Coneixement (2017SGR1355). G. Mezquida is a Serra Húnter Fellow, within the Tenure-elegible Lecturer Serra Hunter program (UB-LE-212–024, Generalitat de Catalunya). M. F. Forte received the support of “Contratos predoctorales de formación en investigación en salud" (PFIS22) (FI22/00185) from the Instituto de Salud Carlos III (ISCIII) with European funds from the Recovery, Transformation and Resilience Plan, by virtue of the Resolution of the Directorate of the Carlos III Health Institute, O.A., M.P. of December 14, 2022, granting Predoctoral Research Training Contracts in Health (PFIS Contracts). Funded by the European Union NextGenerationEU. S. Amoretti has been supported by Sara Borrell doctoral programme (CD20/00177) and M-AES mobility fellowship (MV22/00002), from the Instituto de Salud Carlos III (ISCIII), and co-funded by European Social Fund “Investing in your future”. E. Vieta thanks the support of the Spanish Ministry of Science, Innovation and Universities (PI18/00805; PI21/00787) integrated into the Plan Nacional de I+D+I and co-financed by ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER); CIBERSAM; and the Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya to the Bipolar Disorders Group (2021 SGR 1358) and the project SLT006/17/00357, from PERIS 2016–2020 (Departament de Salut). CERCA Programme/Generalitat de Catalunya. M. Garriga thanks the support of the Spanish Ministry of Science, Innovation and Universities (PI21/00340) integrated into the Plan Nacional de I+D+I and co-financed by ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER); CIBERSAM; and the Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya to the Bipolar Disorders Group (2021 SGR 1358). CERCA Programme/Generalitat de Catalunya. J.A. Ramos-Quiroga thanks the suport of the CIBERSAM; Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya to the Psychiatry, Mental Health and Addictions Group (2021 SGR 00840). I. Baeza thanks the Spanish Ministry of Science, Innovation and Universities and Instituto de Salud Carlos III (PI21/0391) co-funded by the European Union, the National Drugs Plan (2022 I053) and Fundación Alicia Koplowitz., We would like to thank the Carlos III Healthcare Institute, the Spanish Ministry of Science, Innovation and Universities, the European Regional Development Fund (ERDF/FEDER) (PI08/0208, PI11/00325, PI14/00612, PI14/00753, PI20/00661, and PI24/00196); CIBERSAM; CERCA Program; Government of Catalonia, the Secretariat of Universities and Research of the Department of Enterprise and Knowledge (2021 SGR 01120), the Institut de Neurociències, Universitat de Barcelona, UBNeuro, and the Serra-Hunter Programme, Government of Catalonia. This work was also supported by La Marató-TV3 Foundation grants 202234–32 (to S. Amoretti); 202234–30 (to E. Vieta); 202234–30 (to A. Gonzàlez-Segura), 202225–30 (to R. Penadés). IB thanks Pons Bartran legacy (FCRB_IPB2–2023), and CGR thanks the Maria i Nuria Cunillera legacy (FCRB_CU1_2024) for the support.